alprenolol has been researched along with n(8)-bromoacetyl-n(1)-3'-(4-indolyloxy)-2'-hydroxypropyl-1,8-diamino-4-menthane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Insel, PA; Jasper, JR; Michel, MC | 1 |
| Box, RJ | 1 |
| Insel, PA; Jasper, JR; Motulsky, HJ | 1 |
3 other study(ies) available for alprenolol and n(8)-bromoacetyl-n(1)-3'-(4-indolyloxy)-2'-hydroxypropyl-1,8-diamino-4-menthane
| Article | Year |
|---|---|
Partial agonistic activity of two irreversible beta-adrenergic receptor ligands, bromoacetylated derivatives of alprenolol and pindolol.
Topics: Adrenergic beta-Agonists; Alprenolol; Cell Line; Colforsin; Cyclic AMP; Cyclohexane Monoterpenes; Dose-Response Relationship, Drug; Humans; Pindolol | 1991 |
Quantitative comparison of bromoacetylated derivatives of alprenolol and pindolol on beta-adrenergic receptor binding and mobility in S49 cells.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Cell Membrane; Cyclohexane Monoterpenes; Lipoproteins, LDL; Mice; Pindolol; Receptors, Adrenergic, beta; Transferrin; Tumor Cells, Cultured | 1989 |
Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
Topics: Adrenergic beta-Antagonists; Alprenolol; Alprostadil; Animals; Cyclic AMP; Cyclohexane Monoterpenes; Dose-Response Relationship, Drug; Iodocyanopindolol; Membrane Proteins; Mice; Pindolol; Receptors, Adrenergic, beta; Tumor Cells, Cultured | 1988 |